Jefferies Financial Group Raises HealthEquity (NASDAQ:HQY) Price Target to $90.00

HealthEquity (NASDAQ:HQYGet Rating) had its price objective upped by Jefferies Financial Group from $80.00 to $90.00 in a research report released on Wednesday, The Fly reports. Jefferies Financial Group also issued estimates for HealthEquity’s FY2024 earnings at $1.32 EPS.

Other equities analysts have also recently issued research reports about the company. Raymond James increased their target price on HealthEquity from $70.00 to $75.00 and gave the stock an outperform rating in a report on Monday, September 12th. KeyCorp began coverage on shares of HealthEquity in a research note on Thursday, September 15th. They set an overweight rating and a $85.00 price objective for the company. StockNews.com upgraded shares of HealthEquity from a sell rating to a hold rating in a research note on Saturday, October 29th. Robert W. Baird raised their price objective on shares of HealthEquity from $47.00 to $67.00 and gave the stock a neutral rating in a research report on Wednesday, September 7th. Finally, Wells Fargo & Company lifted their price objective on shares of HealthEquity from $100.00 to $104.00 and gave the company an overweight rating in a research note on Tuesday, October 25th. One analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat, HealthEquity presently has a consensus rating of Moderate Buy and a consensus target price of $77.64.

HealthEquity Stock Up 0.2 %

Shares of HQY opened at $76.31 on Wednesday. HealthEquity has a 12-month low of $36.81 and a 12-month high of $79.20. The firm has a market capitalization of $6.45 billion, a price-to-earnings ratio of -103.12, a P/E/G ratio of 4.15 and a beta of 0.87. The stock’s 50-day moving average price is $70.57 and its 200 day moving average price is $64.83.

HealthEquity (NASDAQ:HQYGet Rating) last announced its earnings results on Tuesday, September 6th. The company reported $0.16 EPS for the quarter, missing the consensus estimate of $0.17 by ($0.01). The business had revenue of $206.14 million during the quarter, compared to analyst estimates of $203.40 million. HealthEquity had a positive return on equity of 2.86% and a negative net margin of 7.82%. During the same period in the previous year, the firm earned $0.21 earnings per share. Equities research analysts expect that HealthEquity will post 0.69 EPS for the current year.

Insider Transactions at HealthEquity

In related news, Director Debra Charlotte Mccowan sold 4,225 shares of HealthEquity stock in a transaction on Tuesday, September 27th. The shares were sold at an average price of $70.91, for a total value of $299,594.75. Following the sale, the director now owns 7,072 shares of the company’s stock, valued at approximately $501,475.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other HealthEquity news, Director Debra Charlotte Mccowan sold 4,225 shares of the firm’s stock in a transaction on Tuesday, September 27th. The stock was sold at an average price of $70.91, for a total value of $299,594.75. Following the transaction, the director now owns 7,072 shares in the company, valued at approximately $501,475.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Delano Ladd sold 5,897 shares of the firm’s stock in a transaction on Friday, October 21st. The shares were sold at an average price of $75.00, for a total value of $442,275.00. Following the completion of the transaction, the executive vice president now owns 37,471 shares in the company, valued at approximately $2,810,325. The disclosure for this sale can be found here. Insiders have sold 46,648 shares of company stock valued at $3,355,690 in the last 90 days. 2.80% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On HealthEquity

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Fifth Third Bancorp lifted its stake in HealthEquity by 15.0% in the first quarter. Fifth Third Bancorp now owns 10,297 shares of the company’s stock valued at $694,000 after buying an additional 1,343 shares during the last quarter. Retirement Systems of Alabama lifted its stake in HealthEquity by 0.3% in the first quarter. Retirement Systems of Alabama now owns 109,694 shares of the company’s stock valued at $7,398,000 after buying an additional 340 shares during the last quarter. Virginia Retirement Systems ET AL purchased a new stake in HealthEquity in the first quarter valued at approximately $661,000. Inspire Investing LLC purchased a new stake in HealthEquity in the first quarter valued at approximately $233,000. Finally, Strs Ohio raised its stake in shares of HealthEquity by 220.0% during the first quarter. Strs Ohio now owns 8,000 shares of the company’s stock worth $539,000 after purchasing an additional 5,500 shares during the last quarter. 99.43% of the stock is owned by institutional investors and hedge funds.

About HealthEquity

(Get Rating)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading

The Fly logo

Analyst Recommendations for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.